Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP-2 in Infants and Children With Intestinal Failure
NCT01573286Phase 2Terminated
- Sponsor
- Alberta Children's Hospital
- Start
- Jan 2012
- Primary completion
- Aug 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of glucagon-like peptide-2 in intestinal failure (IF), short bowel syndrome (SBS), sponsored by Alberta Children's Hospital. Started Jan 2012; status: terminated.
02
Drugs
glucagon-like peptide-2
03
Conditions
intestinal failure (IF)short bowel syndrome (SBS)
Beyond the preview
Go deeper on NCT01573286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01573286.